Previous close | 1,513.00 |
Open | 1,497.00 |
Bid | 1,500.00 x 0 |
Ask | 1,502.50 x 0 |
Day's range | 1,479.00 - 1,502.50 |
52-week range | 1,462.00 - 3,379.00 |
Volume | |
Avg. volume | 3,657,831 |
Market cap | 1.02T |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 22.52 |
EPS (TTM) | 66.69 |
Earnings date | 26 July 2024 - 30 July 2024 |
Forward dividend & yield | 42.00 (2.80%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | 2,330.00 |
M3 Wake Research, a leading fully integrated network of clinical research sites and one of North America's largest providers of Phase I-IV clinical trials, is expanding operations into Charleston, SC with the opening of a clinical research practice. Operating as Charleston Clinical Trials, LLC, the new center is led by Donald Hurley, DO, and located at 2270 Ashley Crossing Drive in Charleston.